Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction

Not Applicable

Active, not recruiting

• Conditions: Transthyretin Amyloid Cardiomyopathy; Heart Failure
• Interventions: Diagnostic Test: Echocardiography

• Registration Number: NCT05896904
• Lead Sponsor: Aarhus University Hospital Skejby

Brief Summary

Clinical comparison of patients with transthyretin cardiac amyloidosis and patients with heart failure with reduced ejection fraction

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-09
• Primary Completion: 2023-03-06
• Status Verified: 2023-05
• Study First Submitted: 2023-05-31
• Study First Submitted QC: 2023-05-31
• Last Update Submitted: 2023-05-31
• Study First Posted: 2023-06-09
• Last Update Posted: 2023-06-09
• Study Completion: 2023-08-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age >65
• ATTRwt diagnosis for patients, either with DPD-scintigraphy or myocardiac biopsy
• informed consent

Exclusion Criteria

• Alder <65
• No ATTRwt diagnosis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Echocardiography	Echocardiography	-

Primary Outcome Measures

Name	Time	Method
intraventricular wall thickness	1 year	echocardiographic measurement

Trial Locations

Locations (1)

Aarhus University Hospital; 🇩🇰 Aarhus, Denmark